From Wikipedia, the free encyclopedia
Combination of
DesogestrelProgestogen (Progestin)
Clinical data
Trade namesMarvelon, Desogen, Ortho-cept, others
Other namesEE/DSG, EE-DSG, DSG+EE
AHFS/Drugs.comProfessional Drug Facts
Routes of
By mouth
ATC code
Legal status
Legal status
CAS Number

Desogestrel/ethinylestradiol (EE/DSG), sold under the brand name Marvelon among others, is a fixed-dose combination of desogestrel (DSG), a progestin, and ethinylestradiol (EE), an estrogen, which is used as a birth control pill to prevent pregnancy in women.[1][2][4][5] It is taken by mouth.[2]

It was approved for medical use in the United Kingdom in 1981,[1] and in the United States in 1992.[2] In 2020, it was the 120th most commonly prescribed medication in the United States, with more than 5 million prescriptions.[6][7]

See also[edit]


  1. ^ a b c "Marvelon Tablets - Summary of Product Characteristics (SmPC)". (emc). 11 March 2021. Retrieved 18 June 2021.
  2. ^ a b c d "Desogen Tablets (desogestrel and ethinyl estradiol tablets USP)". DailyMed. 18 June 2018. Retrieved 18 June 2021.
  3. ^ "List of nationally authorised medicinal products" (PDF). European Medicines Agency.
  4. ^ Pundir J, Coomarasamy A (21 April 2016). Gynaecology: Evidence-Based Algorithms. Cambridge University Press. pp. 260–. ISBN 978-1-316-30110-4.
  5. ^ IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; World Health Organization; International Agency for Research on Cancer (2007). Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. pp. 435, 436, 455, 459. ISBN 978-92-832-1291-1.
  6. ^ "The Top 300 of 2020". ClinCalc. Retrieved 7 October 2022.
  7. ^ "Desogestrel; Ethinyl Estradiol - Drug Usage Statistics". ClinCalc. Retrieved 7 October 2022.